RENTON, Wash. & MENLO PARK, Calif.–(BUSINESS WIRE)–Providence, a not-for-profit health system serving the Western U.S., and GRAIL, LLC, a healthcare company with a mission to detect cancer early when it can be cured, today announced the expansion of their partnership to offer multi-cancer early detection screening as part of clinical care to eligible individuals across the entire Providence health system. Through the partnership, eligible patients at Providence’s 52 hospitals and 900 clinics across seven states will have access to GRAIL’s Galleri® multi-cancer early detection (MCED) test, as part of a comprehensive range of health services. In clinical studies, Galleri has demonstrated…
Author: Rutali Thakur
ATLANTA, March 30, 2023 /PRNewswire/ — Kohlberg & Company (“Kohlberg”), a leading private equity firm headquartered in New York, today announced that it has partnered with United Digestive (“UD”), one of the largest gastroenterology physician practice management firms in the United States. United Digestive offers a unique, fully integrated management platform for gastroenterology practices and has over 200 providers across 80 locations in the Southeastern United States. UD was formed from a partnership between Atlanta Gastroenterology Associates and Frazier Healthcare Partners in December 2018.
Capsulomics, announces official rebrand as Previse and launches their first product to enable accurate prognosis and detection data for those prone to Esophageal Cancer. BALTIMORE, March 21, 2023 /PRNewswire/ — Previse, formerly known as Capsulomics, Inc., announced that the company has closed a $3M seed round and launched its first laboratory-developed test, Esopredict™. Esophageal cancer is one of the most lethal cancers in the world, with a 20% five-year survival rate after diagnosis. According to the American Cancer Society, in 2023, about 21,560 new US cases of esophageal cancer will be diagnosed, and 16,120 people will die from the disease.…